These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12623190)

  • 21. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
    Uner M; Gönüllü U; Yener G; Altinkurt T
    Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
    Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
    Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the release test method for the topical application of pharmaceutical preparations: release test of cataplasm including nonsteroidal anti-inflammatory drugs using artificial sweat.
    Shimamura T; Tairabune T; Kogo T; Ueda H; Numajiri S; Kobayashi D; Morimoto Y
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):167-71. PubMed ID: 14757999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
    Corrigan OI
    Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid in vivo dissolution of ketoprofen: implications on the biopharmaceutics classification system.
    Granero GE; Ramachandran C; Amidon GL
    Pharmazie; 2006 Aug; 61(8):673-6. PubMed ID: 16964708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.
    Sheng JJ; McNamara DP; Amidon GL
    Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and characterization of a new miniaturized rotating disk equipment for in vitro dissolution rate studies.
    Persson AM; Baumann K; Sundelöf LO; Lindberg W; Sokolowski A; Pettersson C
    J Pharm Sci; 2008 Aug; 97(8):3344-55. PubMed ID: 18000821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test.
    Amaral Silva D; Davies NM; Doschak MR; Al-Gousous J; Bou-Chacra N; Löbenberg R
    J Control Release; 2020 Sep; 325():323-334. PubMed ID: 32649973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen.
    Levis KA; Lane ME; Corrigan OI
    Int J Pharm; 2003 Mar; 253(1-2):49-59. PubMed ID: 12593936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
    Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of dissolution test precision for a ketoprofen oral extended-release product.
    Furlanetto S; Maestrelli F; Orlandini S; Pinzauti S; Mura P
    J Pharm Biomed Anal; 2003 Apr; 32(1):159-65. PubMed ID: 12852458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.